Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
O

Onesource Specialty Pharma Ltd
NSE:ONESOURCE

Watchlist Manager
Onesource Specialty Pharma Ltd
NSE:ONESOURCE
Watchlist
Price: 1 552.3 INR 0.94% Market Closed
Market Cap: ₹178B
Write Note Create Alert Ask AI

Wall St Price Targets

ONESOURCE Price Targets Summary
Onesource Specialty Pharma Ltd

Wall Street analysts forecast ONESOURCE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ONESOURCE is 2 097.12 INR with a low forecast of 1 692.76 INR and a high forecast of 2 520 INR.

ONESOURCE Lowest Forecast
Wall Street Target
₹1 692.76
9% Upside
ONESOURCE Average Forecast
Wall Street Target
₹2 097.12
35% Upside
ONESOURCE Highest Forecast
Wall Street Target
₹2 520
62% Upside
Lowest Forecast
Price Target
1 692.76 INR
9% Upside
Average Forecast
Price Target
2 097.12 INR
35% Upside
Highest Forecast
Price Target
2 520 INR
62% Upside
Onesource Specialty Pharma Ltd Competitors:
Price Targets
MNPR
Monopar Therapeutics Inc
10% Upside
MNPR
Monopar Therapeutics Inc
10% Upside

Revenue
Forecast

188% / Year
Past Growth
55% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
188% / Year
Past Growth
55% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Revenue has been 188%. The projected CAGR for the next 2 years is 55%.

What are analyst estimates?

Gross Profit
Forecast

247% / Year
Past Growth
49% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
247% / Year
Past Growth
49% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Gross Profit has been 247%. The projected CAGR for the next 2 years is 49%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
544% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
544% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Operating Income over the next 2 years is 544%.

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Continue ONESOURCE Research

Summary
ONESOURCE intrinsic value, competitors valuation, and company profile.
DCF Valuation
ONESOURCE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ONESOURCE stock valuation using valuation multiples.
Wall St Estimates
ONESOURCE price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ONESOURCE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ONESOURCE's stock price target?
Price Target
2 097.12 INR

According to Wall Street analysts, the average 1-year price target for ONESOURCE is 2 097.12 INR with a low forecast of 1 692.76 INR and a high forecast of 2 520 INR.

What is the Revenue forecast for Onesource Specialty Pharma Ltd?
Projected CAGR
55%

Over the last 2 years, the compound annual growth rate for Revenue has been 188%. The projected CAGR for the next 2 years is 55%.

What is the Gross Profit forecast for Onesource Specialty Pharma Ltd?
Projected CAGR
49%

Over the last 2 years, the compound annual growth rate for Gross Profit has been 247%. The projected CAGR for the next 2 years is 49%.

What is the Operating Income forecast for Onesource Specialty Pharma Ltd?
Projected CAGR
544%

The compound annual growth rate for Operating Income over the next 2 years is 544%.

Back to Top
ALPHA SPREAD
Follow us
Join 356,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett